MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Arbutus Biopharma Corp

Закрыт

4.18 -3.02

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

4.16

Макс.

4.28

Ключевые показатели

By Trading Economics

Доход

27M

2.5M

Продажи

9M

11M

Рентабельность продаж

23.494

Сотрудники

44

EBITDA

27M

2.6M

Рыночная статистика

By TradingEconomics

Рыночная капитализация

215M

855M

Предыдущая цена открытия

7.2

Предыдущая цена закрытия

4.18

Техническая оценка

By Trading Central

Уверенность

Weak Bearish Evidence

Arbutus Biopharma Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 окт. 2025 г., 16:58 UTC

Отчет

BMW Trims 2025 View, Citing Weaker Performance in China

7 окт. 2025 г., 23:43 UTC

Обсуждения рынка

Nikkei May Trade Rangebound; Takaichi's Policy Steps in Focus -- Market Talk

7 окт. 2025 г., 23:36 UTC

Обсуждения рынка

Gold Edges Higher, Supported by Possible Hedging Demand -- Market Talk

7 окт. 2025 г., 23:19 UTC

Обсуждения рынка

Veem Can Secure More Defense Deals Following Northrop Grumman Win -- Market Talk

7 окт. 2025 г., 22:50 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 22:50 UTC

Обсуждения рынка

RBNZ Should Take the Option of a Bigger Cut -- Market Talk

7 окт. 2025 г., 22:40 UTC

Обсуждения рынка

South32's Alaskan Project Seen Starting Sooner, Worth More After U.S. Deal -- Market Talk

7 окт. 2025 г., 21:56 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

7 окт. 2025 г., 21:56 UTC

Обсуждения рынка

Australia Shares Set to Start Day Roughly Flat -- Market Talk

7 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

7 окт. 2025 г., 20:44 UTC

Популярные акции

Stocks to Watch Tuesday Recap: Oracle, Dell, Trilogy Metals -- WSJ

7 окт. 2025 г., 19:42 UTC

Обсуждения рынка

Treasury Yields Fall as Data Blackout Continues -- Market Talk

7 окт. 2025 г., 19:23 UTC

Приобретения, слияния, поглощения

Private-Equity Stocks Have Gotten Crushed. J.P. Morgan Says This One Is a Buy. -- Barrons.com

7 окт. 2025 г., 19:07 UTC

Обсуждения рынка

Oil Futures Settle Mixed With Higher OPEC+ Supply in View -- Market Talk

7 окт. 2025 г., 19:02 UTC

Обсуждения рынка

U.S. Natural Gas Posts Back-to-Back Gains -- Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

7 окт. 2025 г., 16:20 UTC

Обсуждения рынка

Home Depot Extended Pro Desk Hours Could Drive Sales Growth -- Market Talk

7 окт. 2025 г., 16:15 UTC

Обсуждения рынка

AMD's OpenAI Deal Resets Competitive Landscape for Chips -- Market Talk

7 окт. 2025 г., 16:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

7 окт. 2025 г., 15:37 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 15:37 UTC

Обсуждения рынка

Markets for Canadian Aluminum Open Up Beyond U.S. -- Market Talk

7 окт. 2025 г., 15:33 UTC

Обсуждения рынка

Gold Rise Tied to Lower Confidence in Dollar Assets -- Market Talk

7 окт. 2025 г., 15:25 UTC

Обсуждения рынка

Canadian Mining Stocks Rally on U.S. Defense Dept. Deal -- Market Talk

7 окт. 2025 г., 15:15 UTC

Обсуждения рынка

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

7 окт. 2025 г., 15:04 UTC

Обсуждения рынка

Market Talk Roundup: Latest on U.S. Politics

7 окт. 2025 г., 15:04 UTC

Обсуждения рынка

Canadian Aluminum Exports Squeezed by Tariffs -- Market Talk

7 окт. 2025 г., 14:56 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

7 окт. 2025 г., 14:56 UTC

Обсуждения рынка

U.S. Government Shutdown May Impact Release of Canadian Trade Data -- Market Talk

7 окт. 2025 г., 14:52 UTC

Отчет

These Stocks Are Moving the Most Today: Tesla, AMD, Ford, Dell, IBM, AppLovin, Trilogy Metals, Aehr, and More -- Barrons.com

Сравнение c конкурентами

Изменение цены

Arbutus Biopharma Corp Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

3.255 / 3.365Поддержка и Сопротивление

Краткосрочная

Weak Bearish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Weak Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Arbutus Biopharma Corp

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression. The company's research and development programs include AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune system; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has licensing agreements with Gritstone Oncology, Inc; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Barinthus Biotherapeutics plc to evaluate VTP-300. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.
help-icon Live chat